BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22628119)

  • 1. Cancer, concepts, cohorts and complexity: avoiding oversimplification of overdiagnosis.
    Detterbeck FC
    Thorax; 2012 Sep; 67(9):842-5. PubMed ID: 22628119
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer overdiagnosis and overtreatment.
    Klotz L
    Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological aspects of active surveillance.
    van den Bergh RC; Korfage IJ; Bangma CH
    Curr Opin Urol; 2012 May; 22(3):237-42. PubMed ID: 22357407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and surveillance.
    Ouzzane A; Puech P; Villers A
    Curr Opin Urol; 2012 May; 22(3):231-6. PubMed ID: 22388665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer screening--comparison of computed tomography and X-ray.
    Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
    Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prostate cancer Research International: Active Surveillance study.
    Bangma CH; Bul M; Roobol M
    Curr Opin Urol; 2012 May; 22(3):216-21. PubMed ID: 22453333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance: the Canadian experience.
    Klotz L
    Curr Opin Urol; 2012 May; 22(3):222-30. PubMed ID: 22453335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conceptualizing overdiagnosis in cancer screening.
    Marcus PM; Prorok PC; Miller AB; DeVoto EJ; Kramer BS
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery.
    Gould MK
    Thorax; 2011 Apr; 66(4):277-9. PubMed ID: 21357585
    [No Abstract]   [Full Text] [Related]  

  • 10. Lung cancer screening: examining the issues.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS1-6. PubMed ID: 22614958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 5-alpha-reductase inhibitors in active surveillance.
    Margel D; Fleshner N
    Curr Opin Urol; 2012 May; 22(3):243-6. PubMed ID: 22472511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of active surveillance for localized prostate cancer.
    Kim S; Dall'Era MA; Evans CP
    Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early detection of bronchial carcinoma. How effective is screening of risk patients?].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(17):10. PubMed ID: 12808792
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung cancer screening--are we there yet?
    Warner E; Jotkowitz A; Maimon N
    Eur J Intern Med; 2010 Feb; 21(1):6-11. PubMed ID: 20122605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is lung cancer screening using CT a good idea?].
    Smit AA; Moons-Pasic A
    Ned Tijdschr Geneeskd; 2011; 155(50):A3960. PubMed ID: 22186365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of overdiagnosis in lung cancer: a support from molecular biology.
    Barba M; Felsani A; Rinaldi M; Giunta S; Malorni W; Paggi MG
    J Cell Physiol; 2011 Sep; 226(9):2213-4. PubMed ID: 21660943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for lung cancer: New horizons?
    Rossi A; Maione P; Colantuoni G; Gaizo FD; Guerriero C; Nicolella D; Ferrara C; Gridelli C
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):311-20. PubMed ID: 15978829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
    Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on screening for lung cancer.
    Midthun DE; Jett JR
    Semin Respir Crit Care Med; 2008 Jun; 29(3):233-40. PubMed ID: 18506661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.